Urinary Tract Infection

Study shows misunderstanding, misuse of common OTC medication for UTI

Published in Women's Health Weekly, June 17th, 2004

Results of a new survey show that many consumers have a poor understanding of the widely-marketed over-the-counter (OTC) drug phenazopyridine (Pyridium; manufactured by Warner Chilcott), a urinary analgesic for the treatment of pain associated with urinary tract infections.

Collaborating researchers from several California institutions suggest this could lead to under-treatment of urinary tract infections (UTIs), especially among people with limited access to care.

Chih-Wen Shi, MD, MSHS, Department of Family & Preventive Medicine, University of California, San Diego, and colleagues there and at RAND; Veteran's Affairs Greater Los Angeles Healthcare...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2004-06-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry